ArticleTH open : companion journal to thrombosis and haemostasis2023

Rivaroxaban versus Apixaban for Treatment of Cancer-Associated Venous Thromboembolism in Patients at Lower Risk of Bleeding.

Kimberly Snow Caroti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.